Heico Corp: Form 10-Q for the period ended Jul 31, 2023
Filed with the SEC on Aug 30, 2023 and accepted by EDGAR at Aug 30, 2023, 16:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-05-01 to 2023-07-31 | $722.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-11-01 to 2023-07-31 | $2.03bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-05-01 to 2023-07-31 | $444.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2022-11-01 to 2023-07-31 | $1.24bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2023-05-01 to 2023-07-31 | $25.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-11-01 to 2023-07-31 | $68.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-05-01 to 2023-07-31 | $129.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-11-01 to 2023-07-31 | $353.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-05-01 to 2023-07-31 | $149.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-11-01 to 2023-07-31 | $435.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-05-01 to 2023-07-31 | $25.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-11-01 to 2023-07-31 | $77.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-05-01 to 2023-07-31 | $102.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-11-01 to 2023-07-31 | $300.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-05-01 to 2023-07-31 | $0.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-11-01 to 2023-07-31 | $2.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-05-01 to 2023-07-31 | $0.74 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-11-01 to 2023-07-31 | $2.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-05-01 to 2023-07-31 | 138,668,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-11-01 to 2023-07-31 | 138,616,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-11-01 to 2023-07-31 | $300.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-11-01 to 2023-07-31 | $34.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-11-01 to 2023-07-31 | $27.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-07-31 | $694.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-31 | $1.93bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-31 | $5.45bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-31 | $479.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-31 | $2.15bn | us-gaap:Liabilities |
| Current portion of debt | At period end2023-07-31 | $1.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-07-31 | $2.91bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000046619-23-000125. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.